1 Min Read
July 29 (Reuters) - Nabriva Therapeutics Ag
* Novo A/S reports 5 pct passive stake in Nabriva Therapeutics as of July 19, 2016 - SEC Filing Source - bit.ly/2amiXtD Further company coverage: (Bengaluru Newsroom; +1 646 223 8780)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.